Publications
- Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Germline BRCA2 K3326X and CHEK2 I157T Mutations Increase Risk for Sporadic Pancreatic Ductal Adenocarcinoma2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Genotype and Haplotype Analyses of TP53 Gene in Breast Cancer Patients: Association with Risk and Clinical Outcomes2015 | First Faculty of Medicine, Third Faculty of Medicine
- Lack of Replication of Seven Pancreatic Cancer Susceptibility Loci Identified in Two Asian Populations2013 | First Faculty of Medicine
- ABO blood groups and pancreatic cancer risk and survival: Results from the PANcreatic Disease ReseArch (PANDoRA) consortium2013 | First Faculty of Medicine
- Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium2013 | First Faculty of Medicine
- Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk2024 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- MUC13-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...